Thursday, October 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 12, 2026

CORRECTION -- Leverage Shares by Themes Launches 2X Long and -2X Short SpaceX ETFs with 0.75% Fee to Meet Unprecedented Retail Demand

View original at globenewswire.com
CORRECTION -- Leverage Shares by Themes Launches 2X Long and -2X Short SpaceX ETFs with 0.75% Fee to Meet Unprecedented Retail Demand GREENWICH, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Themes ETF Trust, please note that in the first paragraph, the commenceme…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • An investor could lose the full principal value of their investment within a single day if the price of SpaceX falls by more than 50% in one trading day.

    60% confidence
  • Competitor fees in the leveraged single-stock ETF space reach as high as 2.00%.

    60% confidence
  • SpaceX is seeking to raise approximately $75 billion, which would make it the largest IPO in history if completed at that size, surpassing Saudi Aramco's 2019 listing.

    60% confidence
  • SpaceX IPO received more than $250 billion of indications of interest, approximately 3.5 to 4.0 times the planned offering size.

    60% confidence
  • As much as 30% of the SpaceX IPO may be allocated to retail investors.

    60% confidence
  • SSPC's 0.75% management fee is approximately 47% lower than the 1.41% industry average for comparable leveraged ETFs providing -2x SpaceX exposure.

    60% confidence
  • Fees matter immensely in leveraged products where costs can quickly compound and eat into returns; Themes' goal is to combine timely 2x and -2x exposure with strict fee discipline and transparency.

    60% confidence
  • SPCH's 0.75% management fee is approximately 38% lower than the 1.20% industry average for comparable leveraged ETFs providing 2x SpaceX exposure.

    60% confidence
  • Leverage Shares has 160+ ETPs offering both leveraged and unleveraged exposure to single stocks, ETFs, and commodities across various exchanges in Europe.

    60% confidence
  • Retail investors and active traders increasingly want efficient tools to express high-conviction views around major market events, and they shouldn't have to overpay for them.

    60% confidence
  • Leverage Shares has more than $2 billion in assets under management.

    60% confidence

Data points we hold from this source

SpaceX · retail ipo allocation30 percent
SpaceX · ipo indications of interest250 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com
CORRECTION -- Leverage Shares by Themes Launches 2X Long and -2X Short SpaceX ETFs with 0.75% Fee to Meet Unprecedented Retail Demand — Source | Via News | Finance Via News